Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $715K | Sell |
1,904
-62
| -3% | -$23.3K | ﹤0.01% | 1423 |
|
|
2019
Q3 | $545K | Sell |
1,966
-123
| -6% | -$34.1K | ﹤0.01% | 1553 |
|
|
2019
Q2 | $653K | Sell |
2,089
-445
| -18% | -$139K | 0.01% | 1434 |
|
|
2019
Q1 | $1.04M | Sell |
2,534
-863
| -25% | -$354K | 0.01% | 1060 |
|
|
2018
Q4 | $1.27M | Buy |
3,397
+62
| +2% | +$23.2K | 0.01% | 828 |
|
|
2018
Q3 | $1.35M | Buy |
3,335
+153
| +5% | +$61.8K | 0.01% | 819 |
|
|
2018
Q2 | $1.1M | Sell |
3,182
-39
| -1% | -$13.5K | 0.02% | 818 |
|
|
2018
Q1 | $1.11M | Buy |
3,221
+16
| +0.5% | +$5.5K | 0.02% | 805 |
|
|
2017
Q4 | $1.21M | Buy |
3,205
+164
| +5% | +$61.7K | 0.02% | 779 |
|
|
2017
Q3 | $1.36M | Buy |
3,041
+157
| +5% | +$70.2K | 0.02% | 665 |
|
|
2017
Q2 | $1.42M | Sell |
2,884
-202
| -7% | -$99.2K | 0.02% | 600 |
|
|
2017
Q1 | $1.2M | Buy |
3,086
+275
| +10% | +$107K | 0.02% | 630 |
|
|
2016
Q4 | $1.03M | Buy |
2,811
+129
| +5% | +$47.4K | 0.02% | 645 |
|
|
2016
Q3 | $1.08M | Sell |
2,682
-11
| -0.4% | -$4.43K | 0.03% | 609 |
|
|
2016
Q2 | $939K | Buy |
+2,693
| New | +$939K | 0.02% | 645 |
|